Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial

Han, HS; Arun, BK; Kaufman, B; Wildiers, H; Friedlander, M; Ayoub, JP; Puhalla, SL; Bach, BA; Kundu, MG; Khandelwal, N; Feng, D; Bhattacharya, S; Maag, D; Ratajczak, CK; Dieras, V

Han, HS (通讯作者)，H Lee Moffitt Canc Ctr & Res Inst, 10920 McKinley Dr, Tampa, FL 33612 USA.

ANNALS OF ONCOLOGY, 2022; 33 (3): 299

Abstract

Background: In the BROCADE3 trial, addition of the poly(ADP-ribose) polymerase inhibitor, veliparib, to carboplatin/paclitaxel improved progression-fr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索